Ritter Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
RTTR Ritter Pharmaceuticals Inc
FOF Cohen & Steers Closed-End Opportunity Fund
TOO-E Teekay Offshore Partners LP
TBT ProShares UltraShort 20+ Year Treasury
ASDTX AllianzGI Short Duration High Income Fund
ETR Entergy Corp
ET Energy Transfer LP
ESS Essex Property Trust Inc
ES Eversource Energy
EPR EPR Properties
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Pharmaceuticals | Small Cap GrowthCompany profile

Ritter Pharmaceuticals, Inc. develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company's segment is focusing on the development and commercialization of RP-G28. The Company conducts human gut health research by exploring metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into applications intended to have impact on a patient's health. The Company's compound, RP-G28, is under development for the treatment of lactose intolerance. The Company has completed a Phase IIa clinical trial of its product candidate, RP-G28, an orally administered oligosaccharide. RP-G28 is designed to stimulate the growth of lactose-metabolizing bacteria in the colon. The Company has not generated any revenues.

Closing Price
$1.04
Day's Change
-0.01 (-0.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.15
Day's Low
1.03
Volume
(Light)
Volume:
435,349

10-day average volume:
934,007
435,349
  • Prev Close
    1.05
  • Today's Open
    1.14
  • Day's Range
    1.03-1.15
  • Avg Vol (10-day)
    934.0K
  • Last (time)
    3:59p ET 03/21/19
  • Last (size)
    40
  • 52-Wk Range
    0.47 - 4.00
    LowHigh
  • (06/04/18 - 12/27/18)
    121.28%
  • 100.7%
  • Market Cap
    6.0M
  • Shares Outstanding
    5.7M
  • -3.08
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.5
  • 24.28
  • (% of float 02/28/19)
    4.42

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.